LAG-3-BINDING MOLECULKES AND METHODS OF USE THEREOF Application EP-4303235-A2 European Patent Office 10 Jan 2024
LAG-3-binding molecules and methods of use thereof Grant US-11858991-B2 United States of America 02 Jan 2024
Methods of using bispecific molecules having immunoreactivity with PD-1 and CTLA-4 Grant US-11840571-B2 United States of America 12 Dec 2023
Multi-chain polypeptide-containing tri-specific binding molecules Grant US-11820818-B2 United States of America 21 Nov 2023
Bispecific CD16-binding molecules and their use in the treatment of disease Grant US-11795226-B2 United States of America 24 Oct 2023
Tri-specific binding molecules that specifically bind to multiple cancer antigens Grant US-11697684-B2 United States of America 11 Jul 2023
Variant CD3-binding domains and their use in combination therapies for the treatment of… Grant US-11685781-B2 United States of America 27 Jun 2023
PD-1-binding molecules and methods of use thereof Grant US-11623959-B2 United States of America 11 Apr 2023
Bispecific molecules that are immunoreactive with immune effector cells that express an… Grant US-11421031-B2 United States of America 23 Aug 2022
TRI-SPECIFIC BINDING MOLECULES AND METHODS OF USE THEREOF Application EP-3954703-A2 European Patent Office 16 Feb 2022
Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of… Grant US-11098119-B2 United States of America 24 Aug 2021
Combination therapy for the treatment of cancer Grant US-11078279-B2 United States of America 03 Aug 2021
LAG-3-binding molecules and methods of use thereof Grant US-11072653-B2 United States of America 27 Jul 2021
BISPECIFIC MOLECULES THAT ARE IMMUNOREACTIVE WITH IMMUNE EFFECTOR CELLS THAT EXPRESS AN… Application EP-3839044-A1 European Patent Office 23 Jun 2021
B7-H3 binding molecules, antibody drug conjugates thereof and methods of use thereof Grant US-10961311-B2 United States of America 30 Mar 2021
Bispecific molecules that are immunoreactive with immune effector cells that express an… Grant US-10730947-B2 United States of America 04 Aug 2020
Antibodies reactive with B7-H3 and users thereof Grant US-10730945-B2 United States of America 04 Aug 2020
Bispecific molecules comprising an HIV-1 envelope targeting arm Grant US-10717778-B2 United States of America 21 Jul 2020
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof Grant US-10683364-B2 United States of America 16 Jun 2020
Multi-chain polypeptide-containing tri-specific binding molecules Grant US-10647768-B2 United States of America 12 May 2020
Multi-chain polypeptide-containing tri-specific binding molecules that specifically bind… Grant US-10633440-B2 United States of America 28 Apr 2020
PD-1-binding molecules and methods of use thereof Grant US-10577422-B2 United States of America 03 Mar 2020
BCR-complex-specific antibodies and methods of using same Grant US-10479831-B2 United States of America 19 Nov 2019
Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of… Grant US-10160806-B2 United States of America 25 Dec 2018
Methods for the treatment of vascularizing cancers Grant US-10100115-B2 United States of America 16 Oct 2018
Bispecific molecules that are immunoreactive with immune effector cells that express an… Grant US-9908938-B2 United States of America 06 Mar 2018
Antibodies reactive with B7-H3 and uses thereof Grant US-9896508-B2 United States of America 20 Feb 2018
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof Grant US-9714296-B2 United States of America 25 Jul 2017
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof Grant US-9714295-B2 United States of America 25 Jul 2017
BCR-complex-specific antibodies and methods of using same Grant US-9695236-B2 United States of America 04 Jul 2017
BISPECIFIC MOLECULES HAVING IMMUNOREACTIVITY WITH PD-1 AND CTLA-4, AND METHODS OF USE… Application WO-2017106061-A1 World Intellectual Property Organisation (WIPO) 22 Jun 2017
B7-H3L cell surface antigen and antibodies that bind thereto Grant US-9574007-B2 United States of America 21 Feb 2017
Bispecific molecules that are immunoreactive with immune effector cells of a companion… Grant US-9487587-B2 United States of America 08 Nov 2016
Antibodies reactive with B7-H3 and uses thereof Grant US-9441049-B2 United States of America 13 Sep 2016
TRI-SPECIFIC BINDING MOLECULES AND METHODS OF USE THEREOF Application WO-2015184203-A1 World Intellectual Property Organisation (WIPO) 03 Dec 2015
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof Grant US-9150656-B2 United States of America 06 Oct 2015
BCR-complex-specific antibodies and methods of using same Grant US-8993730-B2 United States of America 31 Mar 2015
IMPROVED METHODS FOR THE SELECTION OF PATIENTS FOR PD-1 OR B7-H4 TARGETED THERAPIES, AND… Application WO-2014194293-A1 World Intellectual Property Organisation (WIPO) 04 Dec 2014
ANTI-B7-H5 ANTIBODIES AND THEIR USES Application WO-2014190356-A2 World Intellectual Property Organisation (WIPO) 27 Nov 2014
BISPECIFIC MOLECULES THAT ARE IMMUNOREACTIVE WITH IMMUNE EFFECTOR CELLS THAT EXPRESS AN… Application WO-2014159940-A1 World Intellectual Property Organisation (WIPO) 02 Oct 2014
Antibodies reactive with B7-H3 and uses thereof Grant US-8802091-B2 United States of America 12 Aug 2014
B7-H3L cell surface antigen and antibodies that bind thereto Grant US-8779098-B2 United States of America 15 Jul 2014
ANTI-H7CR ANTIBODIES Application WO-2014100823-A1 World Intellectual Property Organisation (WIPO) 26 Jun 2014
ANTI-HUMAN B7-H4 ANTIBODIES AND THEIR USES Application WO-2014100483-A1 World Intellectual Property Organisation (WIPO) 26 Jun 2014
BCR-complex-specific antibodies and methods of using same Grant US-8669349-B2 United States of America 11 Mar 2014
ANTI-B7-H4 ANTIBODIES AND THEIR USES Application WO-2013025779-A1 World Intellectual Property Organisation (WIPO) 21 Feb 2013
ANTIBODIES REACTIVE WITH B7-H3, IMMUNOLOGICALLY ACTIVE FRAGMENTS THEREOF AND USES THEREOF Application WO-2011109400-A2 World Intellectual Property Organisation (WIPO) 09 Sep 2011